Ignite Creation Date:
2024-05-06 @ 7:44 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06117384
Status:
RECRUITING
Last Update Posted:
2023-11-07
First Post:
2023-10-21
Brief Title:
Systems Oncology Approach to Optimize Ovarian Cancer Treatment
Sponsor:
University of Helsinki
Organization:
University of Helsinki
Study Overview
Official Title:
Systems Oncology Approach to Optimize Ovarian Cancer Treatment
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ONCOSYS-OVA
Brief Summary:
The overall aim is to identify effective therapeutic strategies to ovarian cancer OC using serial tumor ascites and blood samples and carry out state-of-the-art sequencing approaches functional assays and associated bioinformatics to understand mechanisms behind chemoresistance in OC and identify new treatment options for OC patients In this observational trial we will systematically collect analyze and interpret functional molecular and clinical data from real-world ovarian cancer patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None